Director Elizabeth G. O'Farrell of LENSAR, Inc. filed a Form 4 on November 19, 2026, disclosing the exercise of stock options and subsequent sale of shares on November 17 and 18, 2026.
Key Highlights
- Option exercises: O'Farrell exercised stock options covering 22,214 shares on November 17 and 10,961 shares on November 18, both at an exercise price of $3.23 per share.
- Shares sold on November 17: 22,214 shares of common stock were disposed of at a weighted average price of $5.20, with individual transaction prices ranging from $5.00 to $5.285.
- Shares sold on November 18: 10,961 shares were disposed of at a weighted average price of $4.97, with prices ranging from $4.96 to $4.97.
- Remaining beneficial ownership: Following both transactions, O'Farrell directly held 67,368 shares of common stock, according to the filing.
- Options exhausted: After the two exercises, the reported stock option position (expiring May 25, 2033) was reduced to zero derivative securities beneficially owned.
- Option origin: According to the filing, the options were "granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."
LENSAR Director O'Farrell's Two-Day Option Exercise and Share Sale
Elizabeth G. O'Farrell, identified in the filing as a director of LENSAR, Inc. (NASDAQ:LNSR), reported a series of transactions across November 17 and 18, 2026. On both dates, she exercised portions of a stock option originally granted under the company's non-employee director compensation program. The option carried an exercise price of $3.23 per share and was set to expire on May 25, 2033. According to the filing, the option vested in twelve substantially equal monthly installments beginning June 25, 2023, subject to continued service.
On November 17, O'Farrell exercised options for 22,214 shares at $3.23 and sold all 22,214 shares at a weighted average price of $5.20, with individual sales prices ranging from $5.00 to $5.285. The following day, she exercised the remaining 10,961 options at $3.23 and sold those shares at a weighted average price of $4.97, with prices in a range of $4.96 to $4.97. Both weighted average prices are reported in the filing as column 4 figures, with footnotes confirming multiple transactions at the stated ranges.
After the November 17 exercise and sale, O'Farrell's direct beneficial ownership of common stock stood at 67,368 shares. The November 18 transactions left that figure unchanged at 67,368 shares, as the filing reflects the same post-transaction total for both dates. The option position was fully exhausted, with zero derivative securities remaining following the November 18 exercise. The filing was signed by Nicholas T. Curtis as attorney-in-fact on November 19, 2026.
What Was Disclosed
The filing reports two option exercises totaling 33,175 shares and the same-day sale of all exercised shares across November 17-18, 2026. Following both transactions, O'Farrell directly held 67,368 shares of LENSAR common stock and held no remaining options.



Please wait processing your request...